🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This is a randomized, open-label, multi-center, global, Phase III study to ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-06-01
Trial ID
NCT03164616
The main goals are after treatment given before surgery, to measure the num...
Status
Recruiting
Location
Southern Cancer Center (SCC) ( Site 8004)
Start Date
2025-03-20
Trial ID
NCT06788912
The primary objective of this study is to evaluate the objective response r...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-10
Trial ID
NCT07351565
Treatments Being Tested
At present, with the increasing intensities of the tobacco industry and air...
Status
Unknown
Location
The First Hospital of Jilin University
Start Date
2020-08-01
Trial ID
NCT03758677
Treatments Being Tested
Clinical Trial Protocol Primary Objective: To evaluate the efficacy of th...
Status
Not Yet Recruiting
Location
Jiangxi Provincial People's Hospital
Start Date
2025-03-10
Trial ID
NCT06848426
Treatments Being Tested
This is an open label, randomized, Phase II multicenter study designed to e...
Status
Withdrawn
Location
Asklepios Fachkliniken München-Gauting
Start Date
2022-05-20
Trial ID
NCT05383001
Treatments Being Tested
This randomized phase III trial studies chemotherapy and bevacizumab to see...
Status
Completed
Location
Northeast Alabama Regional Medical Center
Start Date
2007-07-19
Trial ID
NCT00324805
This study is designed to determine the efficacy and safety of durvalumab a...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-27
Trial ID
NCT03819465